Navigation Links
Jiangbo Pharmaceuticals Announces Fourth Quarter and Fiscal Year 2010 Results
Date:9/30/2010

The NASDAQ Global Market, which is a significant milestone for our company," commented Mr. Jin, Jiangbo's Chief Executive Officer. "We are encouraged by the SFDA approval of our sustained release Felodipine tablets, which we believe will help counterbalance revenue declines of some of our more mature products such as Itopride and Baobaole Chewable tablets. While we have experienced delays in the renovation of our Hongrui facility for traditional Chinese medicine, we now expect to commence production of six of Hongrui's TCM products in October."

Fourth Quarter Results

Total revenue decreased 5.9% year-over-year to $29.3 million from $31.2 million. The Company carried five drugs during the quarter ended June 30, 2010, with Clarithromycin sustained release tablets accounting for 43.0% of total sales, Itopride Hydrochloride granules 24.4%, Baobaole chewable tablets 16.7%, and Radix Isatidis dispersible tablets 15.7% during the quarter. The year- over-year decrease in fiscal fourth quarter 2010 revenues reflects a 30.5% decline in sales of Baobaole chewable tablets, partly offset by sales increases of Clarithromycin sustained release tablets and Radix Isatidis dispersible tablets by 21.9% and 45.1%, respectively.

Gross profit decreased 8.2% to $21.1 million, from $23.0 million in the comparable period of fiscal year 2009. Gross margin decreased to 72.0% from 73.8% in the year ago quarter, mainly reflecting higher raw material costs for TCM herbs due to natural disasters in Southern China during the second half of fiscal year 2010. During the fourth quarter of fiscal year 2010, TCM accounted for about 20% of total cost of sales.

Selling, general and administrative expenses increased 26.8% to $5.3 million from $4.2 million in the same period of fiscal year 2009, primarily due to more marketing and promotional expenditures in the last quarter of fiscal year 2010 and more public compa
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Jiangbo Pharmaceuticals Chairman to Ring NASDAQ Opening Bell on August 27, 2010
2. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
3. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
4. Jiangbo Pharmaceuticals Announces the Appointment of New Chief Executive Officer
5. Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market
6. Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
7. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
8. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
9. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
10. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
11. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... and LONDON , July 14, 2014 ... IXICO plc (AIM: IXI) jointly announced today the formation ... companies. Dr. Edward Ashton , Ph.D., chief scientific ... have seven members. "The formation of this ... the international commercial and operational alliance we signed with ...
(Date:7/13/2014)... July 13, 2014  Eli Lilly and Company ... from its non-clinical study in genetically engineered mice ... the beta-amyloid antibody N3pG and beta-secretase inhibitor BACE ... more effective in removing clumps of amyloid-beta protein ... thought to lead to Alzheimer,s disease (AD) – ...
(Date:7/11/2014)... 2014 Patient engagement has become a ... are turning to an assortment of marketing activities ... of this evolving approach to patient engagement, marketers ... engage patients throughout their experiences with a disease ... mapping the patient journey and employing a consumer ...
Breaking Medicine Technology:VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 3VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 4VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 5VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 6VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 7VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 8VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 9New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Relieving Drug Market Analysis 2010-2025 , , , ... , Reports details , ... opportunities lie in this diverse market with high, growing demand worldwide? , , ...
... WESTLAKE VILLAGE, Calif. , May 4 ... provider of specialty physician consultations via telemedicine, announced today ... Organization,s 2010 Innovations in Healthcare ABBY Award.  SOC won ... category for their 24/7 teleneurology service that provides immediate ...
Cached Medicine Technology:Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 2Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 3Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 4Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 5Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 6Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 7Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 8Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 9Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 10Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 11Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 12Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 13Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 14Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 15Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 16Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 17Specialists On Call Wins 2010 Innovations in Healthcare ABBY Award 2
(Date:7/14/2014)... 2014 According to a recent ... have discovered a connection between women with high levels ... infertility. Although doctors have theorized about the role stress ... study to provide scientific support. , “Stress, if very ... Dr. Larry Barmat, an OB/GYN who specializes in reproductive ...
(Date:7/14/2014)... could lead to the next generation of treatments of ... when recently evolved genes are damaged, and cells have ... , Astrobiologists Dr Charley Lineweaver from The Australian National ... teamed up with oncologist Dr Mark Vincent from the ... , "The rapid proliferation of cancer cells is ...
(Date:7/14/2014)... 2014 Top nutritional supplement provider ... Quality Control and Assurance Department. As the company continues ... highly-qualified quality assurance (QA) and quality control (QC) officers ... IQ Formulations has become known. , IQ ... of stellar experience and qualifications to their new positions ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 Secure Decisions, ... security, is partnering with the Software Assurance Marketplace (SWAMP) ... improve the software that drives everyday life. , The ... and housed in the Morgridge Institute for Research, is ... to advance software security practices by building a free ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, ... that a faltering sense of smell might signal the ... low-tech smell test could spot who needs more extensive ... decreased ability to identify odors was associated with the ... disease. "We,re trying to be able to diagnose ...
Breaking Medicine News(10 mins):Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:New theory turns cancer on its head 2Health News:Leading Health Supplement Company IQ Formulations Expands Quality Control and Assurance Department 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) ... candy and some medications, teachers are almost as likely to ... by two enterprising elementary schoolers. Casey Gittelman, who,s ... a special medicine cabinet filled with medicine and candies to ...
... research has shown for the first time that omega-3 in ... symptoms of osteoarthritis. According to the University of Bristol ... journal Osteoarthritis and Cartilage , omega-3-rich diets fed to ... per cent compared to a standard diet. The research ...
... 2011 Dr. Michio Kaku, renowned futurist, theoretical physicist, ... keynote speaker at TCT, on Wednesday November 9 at ... Humankind." TCT 2011 Transcatheter Cardiovascular Therapeutics is ... sponsored by the Cardiovascular Research Foundation. More than ...
... for bowel disease is to be set up in London to ... innovation. Building of the 3 million centre of excellence has ... up and running in early 2012. The aim is ... way new surgical breakthroughs are rolled out to hospitals all over ...
... food and drink consumption, smoking and exercise habits. General ... "I only have a few drinks rarely...each week" and ... based on symptoms and a person,s physical appearance just ... for healthcare research and epidemiology that relies on patient ...
... By Jenifer Goodwin HealthDay Reporter , SATURDAY, ... seen in hospital emergency departments don,t believe their weight poses ... never told them otherwise, a new study finds. Researchers ... emergency department at Shands at the University of Florida two ...
Cached Medicine News:Health News:It's Easy to Mistake Medicine for Candy 2Health News:It's Easy to Mistake Medicine for Candy 3Health News:Omega-3 fatty acids shown to prevent or slow progression of osteoarthritis 2Health News:New national research center for bowel disease in London will be a UK first 2Health News:New national research center for bowel disease in London will be a UK first 3Health News:New national research center for bowel disease in London will be a UK first 4Health News:Avoiding bias in medical research 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 3Health News:Many Don't Believe Their Obesity is Unhealthy: Study 4